Statins enhance circulating vitamin E

International Journal of Cardiology

Volumn 123, Issue 2, 2008, Pages 172-174

  Cangemi, Roberto ^a   Loffredo, Lorenzo ^a   Carnevale, Roberto ^a   Pignatelli, Pasquale ^a   Violi, Francesco ^a  

^a Department of Experimental Medicine and Pathology   (Italy)

Author keywords

Metabolic syndrome; Oxidative stress; Statin; Vitamin E

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ATORVASTATIN; CHOLESTEROL; SIMVASTATIN; STATINE DERIVATIVE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; PYRROLES; RETROSPECTIVE STUDIES; SIMVASTATIN; VITAMIN E;

EID: 37149011456     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.115     Document Type: Article

References (12)

1. De Caterina R., Cipollone F., Filardo F.P., et al. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. Circulation 106 (2002) 2543-2549
2. Pratico D., Tangirala R.K., Rader D.J., Rokach J., and FitzGerald G.A. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 4 (1998) 1189-1192
3. Ricciarelli R., Zingg J.M., and Azzi A. Vitamin E: protective role of a Janus molecule. FASEB J 15 (2001) 2314-2325
4. Jula A., Marniemi J., Huupponen R., Virtanen A., Rastas M., and Ronnemaa T. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. JAMA 287 (2002) 598-605
5. Traber M.G., and Jialal I. Measurement of lipid-soluble vitamins-further adjustment needed?. Lancet 355 (2000) 2013-2014
6. Oranje W.A., Sels J.P., Rondas-Colbers G.J., Lemmens P.J., and Wolffenbuttel B.H. Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients. Clin Chim Acta 311 (2001) 91-94
7. Higashi Y., Sasaki S., Nakagawa K., Matsuura H., Oshima T., and Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 346 (2002) 1954-1962
8. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)final report. Circulation 106 (2002) 3143-3421
9. Bieri J.G., Tolliver T.J., and Catignani G.L. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr 32 (1979) 2143-2149
10. Lodge J.K., Hall W.L., Jeanes Y.M., and Proteggente A.R. Physiological factors influencing vitamin E biokinetics. Ann N Y Acad Sci 1031 (2004) 60-73
11. Violi F., Cangemi R., Sabatino G., and Pignatelli P. Vitamin E for the treatment of cardiovascular disease: is there a future?. Ann N Y Acad Sci 1031 (2004) 292-304
12. Meagher E.A., Barry O.P., Lawson J.A., Rokach J., and FitzGerald G.A. Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285 (2001) 1178-1182